These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


154 related items for PubMed ID: 6088634

  • 1. A human monoclonal antibody to cytomegalovirus (CMV).
    Emanuel D, Gold J, Colacino J, Lopez C, Hammerling U.
    J Immunol; 1984 Oct; 133(4):2202-5. PubMed ID: 6088634
    [Abstract] [Full Text] [Related]

  • 2. Characterization of human monoclonal antibodies directed against the pp65-kD matrix antigen of human cytomegalovirus.
    Ohlin M, Sundqvist VA, Gilljam G, Rudén U, Gombert FO, Wahren B, Borrebaeck CA.
    Clin Exp Immunol; 1991 Jun; 84(3):508-14. PubMed ID: 1710548
    [Abstract] [Full Text] [Related]

  • 3. Immunostimulation by cytomegalovirus (CMV): helper T cell-dependent activation of immunoglobulin production in vitro by lymphocytes from CMV-immune donors.
    Yachie A, Tosato G, Straus SE, Blaese RM.
    J Immunol; 1985 Aug; 135(2):1395-400. PubMed ID: 2409150
    [Abstract] [Full Text] [Related]

  • 4. Syngeneic monoclonal anti-idiotype antibodies that bear the internal image of a human cytomegalovirus neutralization epitope.
    Keay S, Rasmussen L, Merigan TC.
    J Immunol; 1988 Feb 01; 140(3):944-8. PubMed ID: 2448380
    [Abstract] [Full Text] [Related]

  • 5. Efficient generation of human anti-cytomegalovirus IgG monoclonal antibodies from preselected antigen-specific B cells.
    Steenbakkers PG, Van Wezenbeek PM, van Zanten J, The TH.
    Hum Antibodies Hybridomas; 1993 Oct 01; 4(4):166-73. PubMed ID: 7504956
    [Abstract] [Full Text] [Related]

  • 6. Human anti-cytomegalovirus (CMV) immunoglobulins secreted by EBV-transformed B-lymphocytes cell lines.
    Amadei C, Michelson S, Frot JC, Fruchart MF, Nicolas H, Boué A.
    Dev Biol Stand; 1984 Oct 01; 57():283-6. PubMed ID: 6098499
    [Abstract] [Full Text] [Related]

  • 7. Renewal of EBV-hybridoma method: efficient generation of recombinant fully human neutralizing IgG antibodies specific for tetanus toxin by use of tetroma cells.
    Ainai A, Kawase T, Ida A, Maeda Y, Ohba H, Ikeda Y, Sato H, Takahashi M, Chiba J.
    Hum Antibodies; 2006 Oct 01; 15(4):139-54. PubMed ID: 17522436
    [Abstract] [Full Text] [Related]

  • 8. SPAM-8, a mouse-human heteromyeloma fusion partner in the production of human monoclonal antibodies. Establishment of a human monoclonal antibody against cytomegalovirus.
    Gustafsson B, Jondal M, Sundqvist VA.
    Hum Antibodies Hybridomas; 1991 Jan 01; 2(1):26-32. PubMed ID: 1651784
    [Abstract] [Full Text] [Related]

  • 9. Production of human monoclonal IgG antibodies reacting with cytomegalovirus (CMV).
    Bron D, Delforge A, Lagneaux L, De Martynoff G, Bosmans E, Van der Auwera P, Snoeck R, Burny A, Stryckmans P.
    J Immunol Methods; 1990 Jul 03; 130(2):209-16. PubMed ID: 2165098
    [Abstract] [Full Text] [Related]

  • 10. Characterization of human anti-cytomegalovirus monoclonal antibody as biologics.
    Masuho Y, Matsumoto Y, Tomiyama T, Sugano T, Ono S.
    Dev Biol Stand; 1990 Jul 03; 71():127-36. PubMed ID: 2169440
    [Abstract] [Full Text] [Related]

  • 11. Generation of human anti-rubella monoclonal antibodies from human hybridomas constructed with antigen-specific Epstein-Barr virus transformed cell lines.
    Hilfenhaus J, Kanzy EJ, Köhler R, Willems WR.
    Behring Inst Mitt; 1986 Jun 03; (80):31-41. PubMed ID: 3019293
    [Abstract] [Full Text] [Related]

  • 12. Human monoclonal antibodies to a genus-specific chlamydial antigen, produced by EBV-transformed B cells.
    Rosén A, Persson K, Klein G.
    J Immunol; 1983 Jun 03; 130(6):2899-902. PubMed ID: 6189902
    [Abstract] [Full Text] [Related]

  • 13. High efficiency creation of human monoclonal antibody-producing hybridomas.
    Dessain SK, Adekar SP, Stevens JB, Carpenter KA, Skorski ML, Barnoski BL, Goldsby RA, Weinberg RA.
    J Immunol Methods; 2004 Aug 03; 291(1-2):109-22. PubMed ID: 15345310
    [Abstract] [Full Text] [Related]

  • 14. Production of anti-tumor human monoclonal antibodies using different approaches.
    Liu H, Xu ZL, Wang Y, Yang L, Feng O, Li Y, Wang YM, Zhang GG.
    Hum Antibodies Hybridomas; 1993 Jan 03; 4(1):2-8. PubMed ID: 8381684
    [Abstract] [Full Text] [Related]

  • 15. A human hybrid myeloma for production of human monoclonal antibodies.
    Kozbor D, Tripputi P, Roder JC, Croce CM.
    J Immunol; 1984 Dec 03; 133(6):3001-5. PubMed ID: 6092464
    [Abstract] [Full Text] [Related]

  • 16. Human monoclonal antibodies to cytomegalovirus recognize viral epitopes on the surface of virus-infected cells.
    Larose Y, Tackaberry ES, Brodeur BR.
    Hum Antibodies Hybridomas; 1991 Apr 03; 2(2):67-73. PubMed ID: 1714785
    [Abstract] [Full Text] [Related]

  • 17. Rescue of human monoclonal antibody production from an EBV-transformed B cell line by fusion to a human-mouse hybridoma.
    Foung SK, Perkins S, Raubitschek A, Larrick J, Lizak G, Fishwild D, Engleman EG, Grumet FC.
    J Immunol Methods; 1984 May 11; 70(1):83-90. PubMed ID: 6201562
    [Abstract] [Full Text] [Related]

  • 18. Monoclonal anti-parasite and anti-RBC antibodies produced by stable EBV-transformed B cell lines from malaria patients.
    Lundgren K, Wahlgren M, Troye-Blomberg M, Berzins K, Perlmann H, Perlmann P.
    J Immunol; 1983 Oct 11; 131(4):2000-3. PubMed ID: 6311902
    [Abstract] [Full Text] [Related]

  • 19. Generation of trispecific cytotoxic T cells recognizing cytomegalovirus, adenovirus, and Epstein-Barr virus: an approach for adoptive immunotherapy of multiple pathogens.
    Karlsson H, Brewin J, Kinnon C, Veys P, Amrolia PJ.
    J Immunother; 2007 Oct 11; 30(5):544-56. PubMed ID: 17589295
    [Abstract] [Full Text] [Related]

  • 20. Generation of hybridomas producing human monoclonal antibodies against human cytomegalovirus.
    Matsumoto Y, Sugano T, Miyamoto C, Masuho Y.
    Biochem Biophys Res Commun; 1986 May 29; 137(1):273-80. PubMed ID: 3013182
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 8.